IMARC Group's report titled “Nucleic Acid Isolation and Purification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global nucleic acid isolation and purification market size reached US$ 5.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Nucleic acid isolation and purification are essential procedures used in forensic analysis and molecular biology to separate DNA and RNA from membranes, proteins, and other cellular materials. These procedures encompass various types, such as total RNA isolation and purification, PCR cleanup, plasmid DNA isolation and purification, microRNA isolation and purification, and more. They play a crucial role in enabling clinicians to process samples efficiently, identify cancer risks, diagnose genetic mutations in patients, develop new therapeutics, and enhance the effectiveness of drugs. As a result, these methods find widespread applications in hospitals, diagnostic centers, academic research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other relevant institutions.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/nucleic-acid-isolation-purification-market/requestsample
Nucleic Acid Isolation and Purification Market Trends and Drivers:
The nucleic acid isolation and purification market is experiencing significant growth due to several factors. One of the key drivers is the increasing prevalence of infectious diseases, chronic disorders, and genetic conditions, which require accurate and efficient nucleic acid analysis. The procedure is widely employed in the pharmaceutical segment to identify microorganisms, detect mutations, and analyze their role in antibiotic resistance, contributing to market growth. Furthermore, the market is benefiting from the introduction of magnetic bead-based extraction kits used in liquid handling platforms. These kits enable the extraction of highly pure nucleic acids from various sources such as blood, tissue, and plant materials, enhancing the efficiency and reliability of the process. Additionally, there is a growing awareness of genomic diagnostics among patients, leading to an increased demand for nucleic acid isolation and purification services. The advancements in genomic sequencing techniques have also improved disease diagnosis, further driving the market.
Moreover, the use of DNA and RNA isolation for routine screening and detection of pathogens and microorganisms, as well as the widespread adoption of polymerase chain reaction (PCR) techniques for detecting genetic abnormalities, are expected to fuel the growth of the nucleic acid isolation and purification market in the coming years. These factors, along with the continuous advancements in technology and the increasing investments in research and development activities by key market players, are expected to propel the market forward.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Kits and Reagents
- Instruments
Breakup by Type:
- Plasmid DNA Isolation and Purification
- Total RNA Isolation and Purification
- Circulating Nucleic Acid Isolation and Purification
- Genomic DNA Isolation and Purification
- Messenger RNA Isolation and Purification
- microRNA Isolation and Purification
- PCR Cleanup
- Others
Breakup by Method:
- Column-Based Isolation and Purification
- Magnetic Bead-Based Isolation and Purification
- Reagent-Based Isolation and Purification
- Others
Breakup by End User:
- Hospitals and Diagnostic Centers
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abcam plc
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Macherey-Nagel Gmbh & Co. Kg
- New England Biolabs
- Norgen Biotek Corp.
- Omega Bio-Tek Inc.
- Promega Corporation
- Qiagen
- Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG)
- Takara Bio Inc. (Takara Holdings Inc.)
- Thermo Fisher Scientific Inc.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163